Dr. Fernando Martinez has joined Alvotech as the Head of our new integration effort, the establishment of a specialty Contracted Development & Manufacturing Organization (CDMO) leveraging Alvotech’s state-of-the-art infrastructure and expertise. Fernando will report directly to CEO and be located out of his home office in Madrid, Spain.
Fernando has spent nearly two decades in R&D with significant senior management experience building and leading multi-disciplinary teams and has a strong track record of delivering success in the pharmaceutical contract service industry.
Fernando is joining Alvotech from Covance, where he led the interventional peri-post approval and RWE clinical research business. Prior to that, he held global executive roles in several market-leading CROs, with responsibilities ranging across Corporate and Business Development, Strategic Alliances & M&A, and the management of clinical research staff in traditional and emerging markets.
As a thoughtful and well-recognized leader in the industry, Fernando sits on the board of ACRP, the world’s largest association of clinical research professionals and is frequently invited to speak at renowned international conferences.
Fernando holds a PhD in Medicinal Chemistry from the University of Bristol (United Kingdom), as well as an MBA from Universidad Politécnica de Madrid. He received his MSc. from the Westfälische Wilhelms-Universität Münster (Germany).